ILanifibranor
Kuphando lwenzululwazi kuphela, hayi izigulane.
Iinkcukacha zeMveliso
Iithegi zeMveliso
| Ubungakanani bePakethi | Ubukho | Ixabiso (USD) |
| 100mg | Ikhona evenkileni | 500 |
| 500mg | Ikhona evenkileni | 800 |
| 1g | Ikhona evenkileni | 1200 |
| Iisayizi ezininzi | Fumana iiQuotes | Fumana iiQuotes |
Igama leMchiza:
4-(1-(benzo[d]thiazol-6-ylsulfonyl)-5-chloro-1H-indol-2-yl)butanoic acid
Ikhowudi yoncumo:
O=C(O)CCCC(N1S(=O)(C2=CC=C3N=CSC3=C2)=O)=CC4=C1C=CC(Cl)=C4
Ikhowudi ye-InChi:
InChI=1S/C19H15ClN2O4S2/c20-13-4-7-17-12(8-13)9-14(2-1-3-19(23)24)2 2(17)28(25,26)15-5-6-16-18(10-15)27-11-21-16/h4-11H,1-3H2,(H,23,24)
Isitshixo se-InChi:
OQDQIFQRNZIEEJ-UHFFFAOYSA-N
Igama elingundoqo:
Lanifibranor, IVA-337, IVA337, IVA 337, 927961-18-0
Ukunyibilika:Inyibilika kwi-DMSO
Ugcino:0 - 4°C ixesha elifutshane (iintsuku ukuya kwiiveki), okanye -20°C ixesha elide (iinyanga).
Inkcazo:
I-Lanifibranor, eyaziwa ngokuba yi-IVA-337, i-agonist ye-peroxisome proliferator-activated receptors (PPAR).
Ithagethi: PPAR
